Alternate Health’s CanaCard Launches Across Canada
Ryan Allway
July 31st, 2017
News, Top News
Canada’s medical cannabis industry is expected to reach over C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of recreational marijuana nationwide. Many patients are interested in obtaining medical cannabis, but the process of applying for a license and choosing the right strain can be difficult and time-consuming. The good news is that several companies are looking to make the process a lot easier.
In this article, we will look at Alternate Health Corp.’s (CSE: AHG) (CNSX: AHG) (OTCQB: AHGIF) recent agreement with National Access Cannabis and its launch across Canada.
National Access Cannabis
Alternate Health recently announced an agreement to invest $1 million into National Access Cannabis (“NAC”) and launch its CanaCard Patient Management System across its ten clinics. The investment in the clinics could provide the company with a valuable equity interest, while the expansion into its clinics could accelerate its strategy to launch CanaCard into a growing number of health clinics throughout Canada focused on medical cannabis.
National Access Cannabis connects patients with clear information on legal treatment options. In particular, their consultants guide patients through the process of obtaining the required legal documents to possess medical cannabis and connect them with a suitable licensed producer approved by Health Canada. NAC helps patients select the appropriate strain for their condition with the help of a medical doctor to maximize therapeutic benefits.
In addition to its in-person clinics, NAC offers in-home telemedicine appointments to people who meet the needed requirements. Every patient is also provided with access to extensive education and resources along with a convenient medical cannabis identification card. This card can be used when traveling to access NAC centers across the country, as well as help with verifying the need for medications when needed.
CanaCard Integration
Alternate Health will integrate its cloud-based CanaCard Patient Management System into these locations to manage the end-to-end transactions involved with providing safe access to medical cannabis. The database connects patients, certified doctors, and licensed producers with a complete set of patient management tools, while ensuring the secure storage of personal data, account balances, transactional volume, and research data.
The company will generate revenue from the transaction fees charged on sales patient patients and licensed producers of medical marijuana, compliant with Health Canada’s rules and guidelines for medical cannabis in Canada. The agreement could help springboard the technology into the Canadian marketplace, given the NAC’s significant reach across Canada, and potentially open the door to similar clinics.
“Alternate Health is taking a step forward in consolidating our leadership position in medical cannabis technology,” said Alternate Health Corp. CEO Dr. Jamison Feramisco in a recent press release announcing the deal. “National Access Cannabis is a Canadian pioneer in medical marijuana and we are excited to see our technology help NAC benefit patients and generate revenue in a key area of both of our businesses.”
Looking Ahead
Alternate Health Corp. (CSE: AHG) (OTCQB: AHGIF) represents a strong investment opportunity in the burgeoning Canadian market. With its expansion into National Access Cannabis clinics, the company has dramatically increased its footprint in a move that could help expand its user base and draw in more clinics as partners. Investors may want to keep a close eye on the stock as it rolls out the system and looks to the future.
The company’s compliance solutions could also be rolled out into other markets down the road, including the United States. Since medical marijuana remains federally illegal, compliance with individual state regulations is of the utmost importance for dispensaries looking to maintain and grow their business amidst the shifting regulatory environment.
Additionally, Alternate Health could be an attractive opportunity for U.S. investors looking to stay away from companies that handle the drug itself. The company recently reported positive cash flow in its first quarter of operation, reporting Non IFRS Adjusted EBITDA of $1.4 million on revenue of $3.87 million. These revenues stem mostly from its clinical lab subsidiary, Alternate Health Labs.
The company anticipates multi-faceted growth, however, over the coming quarters. “Our success this quarter proves there’s a high demand for our services and that we have the commitment and capability to meet that demand,” said Dr. Feramisco. “We expect our software and education businesses to begin generating revenues next quarter, with our cannabinoid research and delivery system business following up in the third and fourth quarters.”
For more information, visit the company’s website or CannabisFN’s company profile.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Technical420 is the premier provider of research and analysis on cannabis stocks. We provide investors with sponsored and non-sponsored information on the volatile and emerging cannabis industry. “Our research is our passion!” Your profit is our reward!
In addition to his role as Founder and CEO at MAZAKALI, Sumit is a consultant to The Arcview Group and the Managing Partner of Emerald Ventures. A frequent speaker at investment seminars, Sumit acts as a mentor to Arcview and Canopy companies and serves on the Canopy Investment committee as well as the NCIA Finance […]
Mindleap is developing an advanced digital health platform that will provide support for people that are looking to achieve personal transformations and overcome mental health challenges.
Cansortium is a US Based, vertically integrated cannabis company with a global mission: deliver the highest standards of cannabis care from nursery to lab to shelf.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
